Cole and Siciliano of CBRE/NE represent Corbus in 32,733 s/f lease

October 06, 2017 - Front Section
500 River Ridge Drive - Norwood, MA

Norwood, MA According to CBRE/New England, Corbus Pharmaceuticals has strengthened its relationship with Cornerstone Corp., entering into an agreement with the management agent for River Ridge Office Park, to expand and relocate within River Ridge Office Park. The phase 3 clinical-stage pharmaceutical company will move into a newly renovated 32,733 s/f facility at 500 River Ridge Dr. from a 10,414 s/f space at 100 River Ridge Dr. 

“Corbus has grown significantly since its founding in 2014, with our lead drug anabasum demonstrating positive Phase 2 clinical results in systemic sclerosis and cystic fibrosis,” said Corbus CFO Sean Moran. “We are rapidly expanding our staff to continue the development of anabasum and have outgrown our existing space. Norwood has proven to be a very appealing location as it offers great value and provides a short, convenient commute for our employees. By continuing to work with Cornerstone, our expansion in River Ridge Office Park in Norwood has been fast and seamless. We are readying to move in early 2018.”

Peter Celona of Cornerstone said, “We are thrilled to strengthen and expand our relationship with an innovative, growing biotech company such as Corbus Pharmaceuticals. We are pleased that Corbus continues to see the value that Norwood and River Ridge Office Park offer its employees and business.”

CBRE/NE’s Curtis Cole and Matt Siciliano represented Corbus. CBRE/NE’s Nat Kessler and Patrick Joyce represented Cornerstone. 

500 River Ridge Dr. is a office building located on Rte. 1 with access to shopping and restaurants. The property was renovated in 2016, featuring a new café, conference/training rooms, lobby, roof and parking lots. A Marriott Courtyard Hotel is located next door, as well as services and retail amenities on Rte. 1. 

500 River Ridge Dr. is accessible via Rte. 128 or from two nearby exits off I-95 (three highway access points).

Tags:

Comments

Add Comment